### 促甲状腺素受体抗体

[促甲状腺素受体抗體](../Page/促甲状腺激素受体.md "wikilink")（TSH receptor antibodies，TRAbs）氏一類以促甲状腺素受体（TSH receptor）為目標抗原的自體抗體。該受體屬於[G蛋白偶联受体](../Page/G蛋白偶联受体.md "wikilink")，負責甲狀腺素相關的訊息傳遞。TRAb可按照其對於促甲状腺素受体的影像分為活化性抗體（與甲狀腺機能亢進相關）、阻斷型（與甲狀腺炎相關），及中和型（不影響受體）。活化和阻斷型抗体主要是構型表位，中和性抗體則主要與抗原的線性表位結合。

抗体氨基端的促甲状腺激素受体显示了刺激活动，而结合残留261-370或388-403块的活动。 TRAbs存在70-100%的 [弥漫性毒性甲状腺肿](../Page/弥漫性毒性甲状腺肿.md "wikilink") (85-100%用于激活抗体和75-96%用于阻止抗体)和1-2%的通常的个人。\[1\]\[2\]\[3\]

激活TRAbs特点的坟墓的疾病(自身免疫性甲状腺机能亢进的)。 TPO抗体测量更易于促甲状腺激素受体抗体，并因此经常被用来作为一个替代的诊断坟墓的疾病。 这些抗体激活腺苷酸环化酶通过结合到促甲状腺激素受体。 这会导致生产的甲状腺激素和后续的增长和血管形成的甲状腺。\[4\] TRAbs也用于诊断的 坟墓夫斯眼病. 虽然的确切机制如何TRAbs诱导坟墓夫斯眼病是未知的，也是可能的抗体结合以促甲状腺激素受体在眼眶组织，造成渗透的淋巴细胞。 这炎反应导致 [细胞](../Page/细胞因子.md "wikilink") 的生产，导致 [成纤维](../Page/成纤维细胞.md "wikilink") 生产 [糖](https://zh.wikipedia.org/wiki/糖胺聚糖 "wikilink")，导致夫斯眼病.\[5\]\[6\]

阻止TRAbs(也称为促甲状腺激素结合抑制免疫球蛋白(TBII))具有竞争力的框活动的促甲状腺激素受体上的。 这可能会导致甲状腺机能减退以通过减少thyrotropic影响TSH的。 他们发现，在桥下的甲状腺炎和坟墓的疾病和可以引起的波动的甲状腺功能在后者。 在治疗过程中的坟墓疾病，他们也可能成为主要的抗体，这可能会导致甲状腺功能减退。\[7\]\[8\]

临床和生理性中的抗体仍然不清楚。 然而，他们可以参与延长了促甲状腺激素受体它的半衰期的。\[9\]

### 甲状腺球蛋白的抗体

甲状腺球蛋白的抗体是具体针对甲状腺球蛋白，660kDa矩阵的蛋白质过程中所涉及的甲状腺激素的产生。 他们发现，在70%的桥本的甲状腺炎，60%的发性甲状腺机能减退，30%的坟墓疾病，一小部分甲状腺癌和3％的正常个人。\[10\]\[11\] 反TPO抗体都存在99％的情况下，甲状腺球蛋白的抗体是存在的，然而只有35%的抗TPO抗体阳性情况也证明了甲状腺球蛋白的抗体。\[12\]

### 反Na<sup>+</sup>/I<sup>−</sup> 转运

反Na<sup>+</sup>/I<sup>−</sup> 转运的抗体是一个较新的发现可能的甲状腺自身抗体和它们的作用在甲状腺疾病仍然是不确定的。 他们现在大约20%的弥漫性毒性甲状腺肿和24%的桥本的甲状腺炎。\[13\]

## 发病机理

生产抗体在弥漫性毒性甲状腺肿被认为是出现的过激活的 [CD4+T-细胞](../Page/輔助型T細胞.md "wikilink")，然后由 [B-小区](../Page/B细胞.md "wikilink") 招募成甲状腺。 这些B-细胞抗体产生特定的甲状腺的抗原。 在桥下的甲状腺炎、激活的CD4+T-细胞产生 [干扰素γ](../Page/干扰素伽玛.md "wikilink")，造成甲状细胞显示 慧类二分子的。 这扩大了自身反应的T-细胞剧和延长的发炎反应。\[14\]

同时防甲状腺的抗体是用于轨道的存在自身免疫性甲状腺炎，他们通常不被认为直接有助于销毁甲状腺。\[15\] Activating TRAbs are characteristic of Graves' disease (autoimmune hyperthyroidism). TPO antibody is measured more easily than the TSH receptor antibody, and so is often used as a surrogate in the diagnosis of Graves' disease. These antibodies activate adenylate cyclase by binding to the TSH receptor. This causes the production of thyroid hormones and subsequent growth and vascularisation of the thyroid.\[16\] TRAbs are also useful in the diagnosis of . Although the exact mechanism of how TRAbs induce Graves' Ophthalmopathy is unknown, it is likely that the antibodies bind to TSH receptors in retro-orbital tissues, causing infiltration of lymphocytes. This inflammatory response leads to [cytokine](../Page/细胞因子.md "wikilink") production that causes [fibroblasts](../Page/成纤维细胞.md "wikilink") to produce [glycosaminoglycans](https://zh.wikipedia.org/wiki/糖胺聚糖 "wikilink"), leading to ophthalmopathy.\[17\]\[18\]

Blocking TRAbs (also known as Thyrotropin Binding Inhibitory Immunoglobulins (TBII)) competitively block the activity of TSH on the receptor. This can cause hypothyroidism by reducing the thyrotropic effects of TSH. They are found in Hashimoto's thyroiditis and Graves' disease and may be cause of fluctuation of thyroid function in the latter. During treatment of Graves' disease they may also become the predominant antibody, which can cause hypothyroidism.\[19\]\[20\]

The clinical and physiological relevance of neutral antibodies remains unclear. However, they may be involved in prolonging the TSH receptor halflife.\[21\]

### 抗甲狀腺素抗體

Thyroglobulin antibodies are specific for thyroglobulin, a 660kDa matrix protein involved in the process of thyroid hormone production. They are found in 70% of Hashimoto's thyroiditis, 60% of idiopathic hypothyroidism, 30% of Graves' disease, a small proportion of thyroid carcinoma and 3% of normal individuals.\[22\]\[23\] Anti-TPO antibodies are present in 99% of cases where thyroglobulin antibodies are present, however only 35% of anti-TPO antibody positive cases also demonstrate thyroglobulin antibodies.\[24\]

### Anti–Na<sup>+</sup>/ I<sup>−</sup> symporter

Anti-Na<sup>+</sup>/I<sup>−</sup> symporter antibodies are a more recent discovery of possible thyroid autoantibodies and their role in thyroid disease remains uncertain. They are present in approximately 20% of Graves' disease and 24% of Hashimoto's thyroiditis.\[25\]

## Pathogenesis

The production of antibodies in Graves' disease is thought to arise by activation of [CD4+ T-cells](../Page/輔助型T細胞.md "wikilink"), followed by [B-cell](../Page/B细胞.md "wikilink") recruitment into the thyroid. These B-cells produce antibodies specific to the thyroid antigens. In Hashimoto's thyroiditis, activated CD4+ T-cells produce [interferon-γ](../Page/干扰素伽玛.md "wikilink"), causing the thyroid cells to display . This expands the autoreactive T-cell repertoire and prolongs the inflammatory response.\[26\]

While anti-thyroid antibodies are used to track the presence of autoimmune thyroiditis, they are generally not considered to contribute directly to the destruction of the thyroid.\[27\]

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.
17.

18.

19.
20.
21.
22.
23.

24.

25.
26.

27.